More recently, human fetal hepatocyte organoids were used for modeling free fatty acid loading, interindividual genetic variability (PNPLA3 I148M), monogenic lipid disorders (APOB and MTTP mutations), and induced non-alcoholic fatty liver disease (NAFLD). Here, MT-TP is linked to metabolic dysfunction-associated steatotic liver disease.